miR-221 facilitates the TGFbeta1-induced epithelial-mesenchymal transition in human bladder cancer cells by targeting STMN1

RETRACTED ARTICLE: STMN-1 is a potential marker of lymph node metastasis in distal esophageal adenocarcinomas and silencing its expression can reverse malignant phenotype of tumor cells

(2014) Javed Akhtar et al.   BMC CANCER

miR-221/222 control luminal breast cancer tumor progression by regulating different targets

(2014) Patrizia Dentelli et al.   CELL CYCLE

MicroRNA-451 induces epithelial–mesenchymal transition in docetaxel-resistant lung adenocarcinoma cells by targeting proto-oncogene c-Myc

(2014) Dongqin Chen et al.   EUROPEAN JOURNAL OF CANCER

Wnt5a Suppresses Colon Cancer by Inhibiting Cell Proliferation and Epithelial-Mesenchymal Transition

(2014) Runfen Cheng et al.   JOURNAL OF CELLULAR PHYSIOLOGY

The MicroRNA Expression Signature of Bladder Cancer by Deep Sequencing: The Functional Significance of the miR-195/497 Cluster

(2014) Toshihiko Itesako et al.   PLoS One

MiR-7, Inhibited Indirectly by LincRNA HOTAIR, Directly Inhibits SETDB1 and Reverses the EMT of Breast Cancer Stem Cells by Downregulating the STAT3 Pathway

(2014) Hongyi Zhang et al.   STEM CELLS

SIRT4 Prevents Hypoxia-Induced Apoptosis in H9c2 Cardiomyoblast Cells

(2013) Ban Liu et al.   CELLULAR PHYSIOLOGY AND BIOCHEMISTRY

MicroRNA-221 promotes colorectal cancer cell invasion and metastasis by targeting RECK

(2013) Jun Qin et al.   FEBS LETTERS

MiR-221 promotes the development of androgen independence in prostate cancer cells via downregulation of HECTD2 and RAB1A

(2013) T Sun et al.   ONCOGENE

RNAi-mediated stathmin suppression reduces lung metastasis in an orthotopic neuroblastoma mouse model

(2013) F L Byrne et al.   ONCOGENE

miR-221/222 Targets Adiponectin Receptor 1 to Promote the Epithelial-to-Mesenchymal Transition in Breast Cancer

(2013) Michael S. Hwang et al.   PLoS One

TACC3 Is Essential for EGF-Mediated EMT in Cervical Cancer

(2013) Geun-Hyoung Ha et al.   PLoS One

Overexpression of stathmin 1 confers an independent prognostic indicator in nasopharyngeal carcinoma

(2013) Han-Ping Hsu et al.   TUMOR BIOLOGY

Inhibition of Stathmin1 Accelerates the Metastatic Process

(2012) K. Williams et al.   CANCER RESEARCH

Stathmin 1: a protein with many tasks. New biomarker and potential target in cancer

(2012) John Nemunaitis   EXPERT OPINION ON THERAPEUTIC TARGETS

Epithelial-to-mesenchymal transition in prostate cancer: paradigm or puzzle?

(2011) Jones T. Nauseef et al.   Nature Reviews Urology

A Perspective on Cancer Cell Metastasis

(2011) C. L. Chaffer et al.   SCIENCE

miR-221/222 Targeting of Trichorhinophalangeal 1 (TRPS1) Promotes Epithelial-to-Mesenchymal Transition in Breast Cancer

(2011) S. Stinson et al.   Science Signaling

Epithelial-Mesenchymal Transition (EMT) in Tumor-Initiating Cells and Its Clinical Implications in Breast Cancer

(2010) Chad J. Creighton et al.   JOURNAL OF MAMMARY GLAND BIOLOGY AND NEOPLASIA

MicroRNA-221 silencing predisposed human bladder cancer cells to undergo apoptosis induced by TRAIL

(2009) Qiang Lu et al.   UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS

Stathmin 1: a novel therapeutic target for anticancer activity

(2008) Shushan Rana et al.   Expert Review of Anticancer Therapy

The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1

(2008) Philip A. Gregory et al.   NATURE CELL BIOLOGY

The global burden of urinary bladder cancer

(2008) D. Maxwell Parkin   SCANDINAVIAN JOURNAL OF UROLOGY AND NEPHROLOGY